Understanding and assessing adverse drug reactions

Journal of Psychosocial Nursing and Mental Health Services

Volumn 49, Issue 10, 2011, Pages 13-15

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054725653     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20110915-01     Document Type: Article

References (10)

1. Bäckström, M., Mjörndal, T., & Dahlqvist, R. (2003). Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiology and Drug Safety, 11, 647-650
2. Howland, R.H. (2008a). Understanding the placebo effect. Part 1: Placebo use in clinical trials. Journal of Psychosocial Nursing and Mental Health Services, 46(5), 17-20.
3. Howland, R.H. (2008b). Understanding the placebo effect. Part 2: Underlying psychological and neurobiological processes. Journal of Psychosocial Nursing and Mental Health Services, 46(6), 15-18.
4. Hutchinson, T.A., & Lane, D.A. (1989). Assessing methods for causality assessment of suspected adverse drug reactions. Journal of Clinical Epidemiology, 42, 5-16.
5. Lazarou, J., Pomeranz, B.H., & Corey, P.N. (1998). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association, 279, 1200-1205.
6. Morrison-Griffiths, S., Walley, T.J., Park, B.K., Breckenridge, A.M., & Pirmohamed, M. (2003). Reporting of adverse drug reactions by nurses. Lancet, 361, 1347-1348.
7. Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., Greenblatt, D.J. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics, 30, 239-245.
8. Pirmohamed, M., & Park, B.K. (2001). Genetic susceptibility to adverse drug reactions. Trends in Pharmacological Sciences, 22, 298-305.
9. Wester, K., Jönsson, A.K., Spigset, O., Druid, H., & Hägg, S. (2008). Incidence of fatal adverse drug reactions: A population based study. British Journal of Clinical Pharmacology, 65, 573-579.
10. Wilke, R.A., Lin, D.W., Roden, D.M., Watkins, P.B., Flockhart, D., Zineh, I., Krauss, R.M. (2007). Identifying genetic risk factors for serious adverse drug reactions: Current progress and challenges. Nature Reviews Drug Discovery, 6, 904-916.